Fiche société
Zai Lab (Shanghai) Co., Ltd.
Traitements, essais et publications liés.
Traitements3programmes
Essais1liés
Publications0liées
SourceDBlocale
Traitements
3| Molécule | Indication / population | Phase | Objectif | Pays | Résultat |
|---|---|---|---|---|---|
| Investigator's Choice of TherapyThe purpose of this study is to evaluate the efficacy and safety of ZL-1310 compared to Investigator's Choice Therapy in participants with relapsed Small Cell Lung Cancer. | Cancer | Phase 3 | À vérifier | United States, Austria, Belgium, China, Czechia, France, Germany, Greece, … | À vérifier |
| ZL-1310The purpose of this study is to evaluate the efficacy and safety of ZL-1310 compared to Investigator's Choice Therapy in participants with relapsed Small Cell Lung Cancer. | Cancer | Phase 3 | À vérifier | United States, Austria, Belgium, China, Czechia, France, Germany, Greece, … | À vérifier |
| ZL-1310The purpose of this study is to evaluate the efficacy and safety of ZL-1310 compared to Investigator's Choice Therapy in participants with relapsed Small Cell Lung Cancer. | Cancer | Phase 3 | À vérifier | United States, Austria, Belgium, China, Czechia, France, Germany, Greece, Italy, Japan, Netherlands, Poland, Spain, Turkey (Türkiye), United Kingdom | À vérifier |
Essais cliniques
1| Molécule | Indication / population | Phase | NCT | Titre | Statut |
|---|---|---|---|---|---|
| ZL-1310 | Cancer | Phase 3 | NCT07218146 | A Study of ZL-1310 Versus Investigator's Choice of Therapy in Participants With Relapsed Small Cell Lung Cancer (DLLEVATE) | RECRUITING |
Publications
0| Molécule | Indication / population | Titre | Journal | Date |
|---|---|---|---|---|
| Aucune publication. | ||||